Literature DB >> 16222761

Autoimmune pancreatitis with IgG4-positive plasma cell infiltration in salivary glands and biliary tract.

Masashi Taguchi1, Gentaro Aridome, Shintaro Abe, Keiichiro Kume, Mitsuo Tashiro, Mitsuyoshi Yamamoto, Yasuyuki Kihara, Hayato Nakamura, Makoto Otsuki.   

Abstract

A 62-year-old male was referred to our hospital because of liver dysfunction, diffuse pancreatic swelling, and trachelophyma. At admission, the patient was free of pain. Physical examination showed enlarged and palpable bilateral submandibular masses, but no palpable mass or organomegaly in the abdomen. Laboratory findings were as follows: total protein 90 g/L with gamma-globulin of 37.3% (33 g/L), total bilirubin 4 mg/L, aspartate aminotransferase 39 IU/L, alanine aminotransferase 67 IU/L, gamma-glutamyl transpeptidase 1 647 IU/L, and amylase 135 IU/L. Autoantibodies were negative, and tumor markers were within the normal range. Serum IgG4 level was markedly elevated (18 900 mg/L). Computed tomography (CT) showed diffuse swelling of the pancreas and dilatation of both common and intra-hepatic bile ducts. Endoscopic retrograde pancreatography (ERP) revealed diffuse irregular and narrow main pancreatic duct and stenosis of the lower common bile duct. Biopsy specimens from the pancreas, salivary gland and liver showed marked periductal IgG4-positive plasma cell infiltration with fibrosis. We considered this patient to be autoimmune pancreatitis (AIP) with fibrosclerosis of the salivary gland and biliary tract, prescribed prednisolone at an initial dose of 40 mg/d. Three months later, the laboratory data improved almost to normal. Abdominal CT reflected prominent improvement in the pancreatic lesion. Swelling of the salivary gland also improved. At present, the patient is on 10 mg/d of prednisolone without recurrence of the pancreatitis. We present here a case of AIP with fibrosclerosis of salivary gland and biliary tract.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16222761      PMCID: PMC4320378          DOI: 10.3748/wjg.v11.i35.5577

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

Review 1.  Autoimmune related pancreatitis.

Authors:  K Okazaki; T Chiba
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

2.  IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis.

Authors:  Shin-ichi Takeda; Joji Haratake; Takahiko Kasai; Chikako Takaeda; Eisuke Takazakura
Journal:  Nephrol Dial Transplant       Date:  2004-02       Impact factor: 5.992

3.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

4.  Salivary gland involvement in chronic pancreatitis of various etiologies.

Authors:  Terumi Kamisawa; Yuyang Tu; Naoto Egawa; Nobuhiro Sakaki; Shigeko Inokuma; Noriko Kamata
Journal:  Am J Gastroenterol       Date:  2003-02       Impact factor: 10.864

5.  Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis.

Authors:  S Tanaka; T Kobayashi; K Nakanishi; M Okubo; T Murase; M Hashimoto; K Takeuchi
Journal:  Lancet       Date:  2000-09-09       Impact factor: 79.321

6.  Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy.

Authors:  Terumi Kamisawa; Naoto Egawa; Shigeko Inokuma; Kouji Tsuruta; Atsutake Okamoto; Noriko Kamata; Teruo Nakamura; Masakatsu Matsukawa
Journal:  Pancreas       Date:  2003-10       Impact factor: 3.327

Review 7.  Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems.

Authors:  Makoto Otsuki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

8.  Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation.

Authors:  Mari Takayama; Hideaki Hamano; Yasuhide Ochi; Hisanobu Saegusa; Kenichi Komatsu; Takashi Muraki; Norikazu Arakura; Yasuharu Imai; Osamu Hasebe; Shigeyuki Kawa
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

9.  Bile duct involvement in a case of autoimmune pancreatitis successfully treated with an oral steroid.

Authors:  Takashi Kuroiwa; Takeshi Suda; Toru Takahashi; Haruka Hirono; Masaaki Natsui; Hirotaka Motoyama; Minoru Nomoto; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

10.  Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis.

Authors:  Yoko Uchiyama-Tanaka; Yasukiyo Mori; Taiko Kimura; Kazuhiro Sonomura; Shigeo Umemura; Noriko Kishimoto; Atsuko Nose; Toshiko Tokoro; Yasuaki Kijima; Hideki Yamahara; Toshiko Nagata; Hiroya Masaki; Yukihisa Umeda; Kazuichi Okazaki; Toshiji Iwasaka
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

View more
  3 in total

1.  Diagnosis and management of autoimmune pancreatitis: experience from China.

Authors:  Yang Song; Quan-Da Liu; Ning-Xin Zhou; Wen-Zhi Zhang; Dian-Jun Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

2.  Complemental Diagnosis of IgG4-Related Pancreaticobiliary Diseases by Multiple Hypoechoic Lesions in the Submandibular Glands.

Authors:  Naruki Shimamura; Shinichi Takano; Mitsuharu Fukasawa; Makoto Kadokura; Hiroko Shindo; Ei Takahashi; Sumio Hirose; Yoshimitsu Fukasawa; Satoshi Kawakami; Hiroshi Hayakawa; Natsuhiko Kuratomi; Hiroyuki Hasegawa; Shota Harai; Dai Yoshimura; Naoto Imagawa; Tatsuya Yamaguchi; Taisuke Inoue; Shinya Maekawa; Tadashi Sato; Nobuyuki Enomoto
Journal:  J Clin Med       Date:  2022-07-19       Impact factor: 4.964

3.  Clinical significance of hypoechoic submandibular gland lesions in type 1 autoimmune pancreatitis.

Authors:  Shinichi Takano; Mitsuharu Fukasawa; Makoto Kadokura; Hiroko Shindo; Ei Takahashi; Sumio Hirose; Yoshimitsu Fukasawa; Satoshi Kawakami; Tadashi Sato; Nobuyuki Enomoto
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.